Utilizing both IgA tissue transglutaminase and IgG-deamidated gliadin peptide antibodies offers accurate celiac disease diagnosis without duodenal biopsy
Digestive and Liver Disease · 2025-02 · 57 (2) · 609-615
DOI: 10.1016/j.dld.2024.10.010 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Digestive and Liver Disease, 2025-02. Verfasst von Fabiana Zingone und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Oncology, Gastroenterology, University of Padua, Padua, Italy; Gastroenterology Unit, Azienda Ospedale Università di Padova, P…. Hauptthemen laut MEDLINE: Celiac Disease, Immunoglobulin A, Gliadin, Immunoglobulin G. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Gastroenterologists still raise concerns about adopting a non-biopsy strategy for diagnosing celiac disease (CeD) in adults. AIM: To assess the performance of the concurrent detection of two autoantibodies targeting two independent antigens, tissue transglutaminase (tTG) and deamidated gliadin peptides (DGP). METHODS: This prospective, multicenter, binational study collected consecutive patients with a high pre-test probability for CeD. Between 2018 and 2020, adults were enrolled at four Italian and one Argentinian center. Serology was also blindly analyzed by a central laboratory (Werfen, San Diego, USA) for tTG IgA and DGP IgG by Aptiva Particle-based multi-analyte technology (PMAT) assays. CeD diagnosis required histological confirmation of Marsh 3 damage. RESULTS: 181 adult patients with suspected CeD were enrolled (134 with histological diagnosis of CeD and 47 not histologically confirmed as CeD). Patients positive for both tTG IgA and DGP IgG (double positive) were predictive of CeD in 92.5 % of patients at >1x upper limit of normal (ULN). Double positivity for tTG IgA and DGP IgG, both at >10x ULN, had a 100 % positive predictive value for the presence of Marsh 3 histology. CONCLUSIONS: Incorporating DGP IgG alongside tTG IgA in a single-step approach can be considered a valid confirmatory strategy for definitive non-biopsy diagnosis of CeD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Oncology, Gastroenterology, University of Padua, Padua, Italy; Gastroenterology Unit, Azienda Ospedale Università di Padova, Padua, Italy.
- Research and Development, Headquarters & Technology Center Autoimmunity, Werfen, San Diego, CA, USA.
- Small Bowel Section, Dr. C. Bonorino Udaondo Gastroenterology Hospital, Buenos Aires, Argentina.
- Department of Surgery, Oncology, Gastroenterology, University of Padua, Padua, Italy.
- Unit of Internal Medicine, PROMISE Department, Villa Sofia Cervello United Hospitals - University of Palermo, Palermo, Italy.
- Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy; Gastroenterology Unit of Pavia Institute, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
Zitieren
APA
Zingone, F., Norman, G. L., Smecuol, E., Maniero, D., Carroccio, A., Biagi, F., Stefanolo, J. P., Niveloni, S., Holmes, G., Villanacci, V., Santonicola, A., Bai, J. C., & Ciacci, C. (2025). Utilizing both IgA tissue transglutaminase and IgG-deamidated gliadin peptide antibodies offers accurate celiac disease diagnosis without duodenal biopsy. Digestive and Liver Disease, 57(2), 609-615. https://doi.org/10.1016/j.dld.2024.10.010
Vancouver
Zingone F, Norman GL, Smecuol E, Maniero D, Carroccio A, Biagi F, et al. Utilizing both IgA tissue transglutaminase and IgG-deamidated gliadin peptide antibodies offers accurate celiac disease diagnosis without duodenal biopsy. Digestive and Liver Disease. 2025;57(2):609-615. doi:10.1016/j.dld.2024.10.010
BibTeX
@article{Zingone2025,
author = {Zingone, Fabiana and Norman, Gary L and Smecuol, Edgardo and Maniero, Daria and Carroccio, Antonio and Biagi, Federico and Stefanolo, Juan P and Niveloni, Sonia and Holmes, Geoffrey and Villanacci, Vincenzo and Santonicola, Antonella and Bai, Julio C and Ciacci, Carolina},
title = {Utilizing both IgA tissue transglutaminase and IgG-deamidated gliadin peptide antibodies offers accurate celiac disease diagnosis without duodenal biopsy},
journal = {Digestive and Liver Disease},
year = {2025},
volume = {57},
number = {2},
pages = {609--615},
doi = {10.1016/j.dld.2024.10.010}
}
EUVIMED